Kavitha, Mani <br/><br/>
Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice.  [electronic resource] 

 -  Chemico-biological interactions  Nov 2013 
 - 239-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7786 
<br/><br/><label>Standard No.: </label>10.1016/j.cbi.2013.09.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Dopaminergic Neurons--pathology<br/>Lipid Peroxidation--drug effects<br/>MPTP Poisoning--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Oxidation-Reduction<br/>Oxidative Stress--drug effects<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Xanthones--pharmacology<br/>bcl-2-Associated X Protein--metabolism